Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment. - Wikidata - awgldk - TriplyDB

Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.

Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.

http://www.wikidata.org/entity/Q38996149

about

Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.New antivirals for the treatment of chronic hepatitis B.Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice.Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report.Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B Checkpoint inhibitor use in two heart transplant patients with metastatic melanoma and review of high-risk populations

P2860

Q38724160-DCDD1FC1-5447-4F07-BA5B-BB2D5973B26E Q39315990-A3BF2B9E-3D13-4F34-9820-69FF0993A9C7 Q45324215-A2166FBF-C4CF-4FA4-AFC8-09DC42EBA232 Q45324931-77253A02-A9FC-4E74-B52B-FE414CD88CF3 Q45325391-9D4D4653-56C4-4CF6-87F4-C4B945E12CA1 Q47562286-A48768DD-ACF1-4C15-B9D0-DB35DAF0599F Q50190669-6FC3A508-50B3-447B-9D3F-9D573D6E0CB2 Q52618967-D9336157-F585-4C19-B580-FCF39F4520E9 Q54216584-0D7DD74B-6076-49A7-BACE-CF30C48506F8 Q58699463-E2F6BAEA-59AB-40C0-9860-EBD15831A741 Q59135661-A31A24A6-E828-483E-9FE2-93EA9109FD9A

P2860

Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.

http://www.wikidata.org/entity/Q38996149

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Hepatitis B virus reactivation ...... systemic anticancer treatment.

@en

type

label

Hepatitis B virus reactivation ...... systemic anticancer treatment.

@en

prefLabel

Hepatitis B virus reactivation ...... systemic anticancer treatment.

@en

P1433

Q38996149-5F0F3B6B-E01B-4A0C-80B9-58AAB1DC1C5C

P1476

Q38996149-1B41BBFC-03E4-49F4-AB21-11BD67AF20BA

P2093

Q38996149-0603BDF3-4605-45D7-8AEF-65AE525B05B4

Q38996149-17DF4FDB-F8BD-4986-866B-833E16376757

Q38996149-48916046-E220-484C-915B-6C19DA0F721E

Q38996149-4ADA7620-0339-4437-AE0F-9E7764EBBFBB

Q38996149-7B66E7D4-B933-4174-AB74-B98FBC46C5F7

Q38996149-9EC8B015-B904-46CE-B064-1F95268CFC12

Q38996149-BABEDEE8-F040-41AE-AA1C-82880E04A16D

Q38996149-D5216830-030D-4B65-AAD8-0AD9949D0A0E

P2860

Q38996149-06C4E229-6069-4070-B46C-DE0D37059989

Q38996149-0CB94434-893D-4297-A855-32964C079C5D

Q38996149-0CD1E1C8-03C6-493F-AAE7-E579FC2DD727

Q38996149-0DBD3DD5-59A1-491D-BFDD-01A03C094326

Q38996149-0F2F9A4E-235E-4676-8525-7B4F4BF34842

Q38996149-123AAEA7-5213-40A4-860E-6655684D4D76

Q38996149-18460BD5-C97F-4B08-9A78-E83443827789

Q38996149-19686B05-A753-4A7A-BDD6-8C1D9BC36BE4

Q38996149-225E95C7-1E6D-4650-A245-9463C00D5903

Q38996149-2707FB7C-9361-4C24-9989-ADF0F8681526

P304

Q38996149-3923FE01-D759-4F8A-8B78-C545BDFD5A2E

P31

Q38996149-229388BD-6DCB-4572-8642-E28CDDA51C91

P356

Q38996149-0936ADEF-1A10-4A40-B211-8A8A0E01064A

P433

Q38996149-94F69546-C501-4BC6-898D-F50A18972CAA

P478

Q38996149-6833C3BE-BA47-40F7-A08D-0813A0562E38

P50

Q38996149-06E71B37-3BD2-48E8-99A7-6C274A57F934

P577

Q38996149-D03696B9-84AC-4B1E-BD5A-7B381DFC34AD

P698

Q38996149-C5EEC237-5124-45EE-A0B5-A96432CDAEC1

P356

P1433

Annals of Oncology

P1476

Hepatitis B virus reactivation ...... systemic anticancer treatment.

@en

P2093

C Brezault

http://www.w3.org/2001/XMLSchema#string

C S Voican

http://www.w3.org/2001/XMLSchema#string

J Dréanic

http://www.w3.org/2001/XMLSchema#string

M Dhooge

http://www.w3.org/2001/XMLSchema#string

P Loulergue

http://www.w3.org/2001/XMLSchema#string

R Coriat

http://www.w3.org/2001/XMLSchema#string

S Chaussade

http://www.w3.org/2001/XMLSchema#string

S Pol

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy for cancer: building on success

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Immunology of hepatitis B virus and hepatitis C virus infection

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient.

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination.

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

P304

2172-2184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDW414

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27803003

http://www.w3.org/2001/XMLSchema#string